New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2019, Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update 2019
View latest version (2019)Bibliographic information
Guideline—
Year of Publication—
Issuing Institution—
Recommendation
Retired
Originally developed
lateral flow urine lipoarabinomannan assay (LF-LAM) should not be used as a screening test for active TB
Recommended against
Strong
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year2016
InstitutionWHO